Welcome to our dedicated page for Houston American SEC filings (Ticker: HUSA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The HUSA SEC filings page aggregates regulatory documents for Houston American Energy Corp., the Delaware corporation that has changed its name to Abundia Global Impact Group, Inc. These filings, accessed from the SEC’s EDGAR system, trace the company’s path from a historical focus on oil and natural gas exploration and production to its current emphasis on circular fuels and renewable energy technologies.
Among the key filings is a Form 8‑K dated December 5, 2025, which reports the amendment to the certificate of incorporation to change the corporate name to Abundia Global Impact Group, Inc. and the related change of the NYSE American trading symbol from “HUSA” to “AGIG.” Other Forms 8‑K detail material events such as the registered direct offering of common stock, the placement agency agreement and associated warrants, amendments to the certificate of incorporation and bylaws to declassify the board, and announcements regarding the timing of the 2025 annual meeting and shareholder proposal deadlines.
Investors can also review the company’s Form 12b‑25 (Notification of Late Filing) explaining the need for additional time to complete the Form 10‑Q for the quarter ended September 30, 2025. That filing discusses complexities arising from a share exchange accounted for as a reverse acquisition and notes that significant changes in results of operations are expected compared with prior periods. Additional 8‑K filings provide preliminary, unaudited financial information, including estimated operating expenses, cash and cash equivalents, goodwill, land assets, and debt levels as of a specific quarter‑end date.
On Stock Titan, these filings are presented with AI‑powered summaries designed to clarify the purpose and main points of each document. Users can quickly see how individual 8‑Ks, proxy statements on Schedule 14A, and notifications like Form 12b‑25 relate to topics such as capital raising, governance changes, name and ticker symbol transitions, and reporting timelines. This structure helps readers understand the regulatory history associated with the HUSA ticker and how it connects to the company’s ongoing operations as Abundia Global Impact Group, Inc.
Abundia Global Impact Group, Inc. director granted stock compensation. Director Robert J. Bailey was awarded 27,875 shares of common stock on January 21, 2026 as compensation for his service on the board. The grant is reported at a price of $0 per share, reflecting that it is an equity award rather than a cash purchase. These shares vest quarterly over twelve months from the grant date under the company’s 2025 Equity Incentive Plan, and Bailey disclaims beneficial ownership until the shares are issued upon vesting. Following this award, 95,875 common shares are reported as beneficially owned in total.
Abundia Global Impact Group, Inc. (AGIG) reported that its Chief Financial Officer, Lucie Harwood, was granted 34,843 shares of common stock on January 21, 2026. The shares were received as compensation for her services as an executive officer at a price of $0 per share and are subject to quarterly vesting over twelve months from the grant date under the company’s 2025 Equity Incentive Plan. Following this grant, she beneficially owns 34,843 shares directly, while disclaiming beneficial ownership until each tranche is issued under the plan.
Abundia Global Impact Group, Inc. director Peter F. Longo reported an award of 27,875 shares of common stock on January 21, 2026. The shares were granted as compensation for his services on the board of directors and carry a reported acquisition price of $0 per share. Following this grant, he reported beneficial ownership of 98,916 shares of common stock in total, held directly.
The awarded shares are subject to quarterly vesting over twelve months from the grant date under the company’s 2025 Equity Incentive Plan, and Longo disclaims beneficial ownership of these shares until they are issued pursuant to that plan.
Abundia Global Impact Group, Inc. director Matthew T. Henninger reported receiving a stock option grant as compensation for his board service. On January 21, 2026, he was awarded a stock option to buy 41,812 shares of common stock at $2.87 per share, expiring on January 21, 2036. The option vests quarterly over twelve months from the grant date, rather than all at once. The filing notes that he disclaims beneficial ownership of the option and the underlying common shares until they are issued under Abundia’s 2025 Equity Incentive Plan. Following this grant, 41,812 derivative securities (options) are shown as beneficially owned directly.
Abundia Global Impact Group’s chief operating officer, Joseph Gasik, was awarded 17,422 shares of common stock on January 21, 2026 as compensation for his services as an executive officer.
The shares were reported at a price of $0 per share and are subject to quarterly vesting over twelve months from the grant date under the company’s 2025 Equity Incentive Plan. Following this grant, 17,422 shares are reported as beneficially owned on a direct basis, although Gasik disclaims beneficial ownership of the shares until they are actually issued pursuant to the plan.
Abundia Global Impact Group, Inc. filed a current report to let investors know it has shared a new letter with its shareholders. The company states that on January 13, 2026 it issued this shareholder letter, which is attached as Exhibit 99.1.
The disclosure is made under Regulation FD, which is meant to ensure important information is available to all investors at the same time. The company also clarifies that this information is being furnished rather than filed, limiting certain legal liabilities, and that the letter is not an offer to sell or a solicitation to buy any securities.
Abundia Global Impact Group, Inc. director Peter F. Longo reported year-end open market purchases of company common stock. On December 19, 2025, he bought 26,041 shares of common stock at a weighted average price of $1.68 per share, with individual trades ranging from $1.59 to $1.69. On December 22, 2025, he purchased an additional 5,000 shares at $1.75 per share. After these transactions, he beneficially owned 71,041 shares of Abundia Global Impact Group common stock, held directly as of the issuer’s fiscal year ended December 31, 2025.
Abundia Global Impact Group, Inc. director Peter F. Longo filed an amended insider trading report to correct details of a prior filing. The amendment states that on June 27, 2025, the board of directors approved a grant of 40,000 shares of common stock at a price of $0 per share. The transaction date in the original report is revised to June 27, 2025.
The amendment also updates Longo’s beneficial ownership to 40,000 shares of common stock held directly. The prior total had mistakenly included 11,917.48 shares issuable upon exercise of stock options that were already reported separately as derivative securities.
Abundia Global Impact Group director Robert J. Bailey reported open market purchases of the company’s common stock on Form 5. On December 19, 2025, he bought 10,000 shares at $1.66 per share. On December 22, 2025, he bought an additional 2,000 shares at $1.90 per share.
After these purchases, Bailey directly beneficially owned 66,000 shares following the first transaction and 68,000 shares after the second, reflecting his updated stake as a director of Abundia Global Impact Group.
Abundia Global Impact Group, Inc. director Robert J. Bailey reported a grant of 56,000 shares of the company’s common stock on June 27, 2025, received at a price of $0 per share. Following this grant, he beneficially owns 56,000 shares directly.
This filing is an amendment to a prior Form 4 filed on July 1, 2025. It corrects the transaction date to June 27, 2025, when the board approved the grant, and also corrects the total beneficial ownership, which previously and erroneously included 1,500 shares issuable upon exercise of stock options reported separately on January 17, 2025.